Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature.

ABSTRACT:

Introduction

On February 11, 2020 WHO designated the name "COVID-19" for the disease caused by "severe acute respiratory syndrome coronavirus 2" (SARS-CoV-2), a novel virus that quickly turned into a global pandemic. Risks associated with acquiring the virus have been found to most significantly vary by age and presence of underlying comorbidity. In this rapid literature review we explore the prevalence of comorbidities and associated adverse outcomes among individuals with COVID-19 and summarize our findings based on information available as of May 15, 2020.

Methods

A comprehensive systematic search was performed on PubMed, Medline, Scopus, Embase, and Google Scholar to find articles published until May 15, 2020. All relevant articles providing information on PCR tested COV

SUBMITTER: Bajgain KT 

PROVIDER: S-EPMC7351042 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature